Novel

antiviral

therapies

Our vision...

We will develop novel antiviral therapies to addess an unmet medical need for treatment of immunocompromised patients. 

Our business idea...

Initial focus on niche indication with possible orphan drug designation, with low competition followed by expansion to major indications with high medical need.

Our company...

Eirium AB was founded in 2012 as a spin-off company from Umeå University, Sweden. Our foundation is based on close collaborations between chemistry and virology expertise.